ArticleJournal for immunotherapy of cancer2023

Venetoclax improves CD20 immunotherapy in a mouse model of MYC/BCL2 double-expressor diffuse large B-cell lymphoma.

Javier Melchor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.